Doxorubicin versus doxorubicin and cisplatin in endometrial carcinoma: definitive results of a randomised study (55872) by the EORTC Gynaecological Cancer Group
Title:
Doxorubicin versus doxorubicin and cisplatin in endometrial carcinoma: definitive results of a randomised study (55872) by the EORTC Gynaecological Cancer Group
Author:
Aapro, M.S. van Wijk, F.H. Bolis, G. Chevallier, B. van der Burg, M.E.L. Poveda, A. de Oliveira, C.F. Tumolo, S. Scotto di Palumbo, V. Piccart, M. Franchi, M. Zanaboni, F. Lacave, A.J. Fontanelli, R. Favalli, G. Zola, P. Guastalla, J.P. Rosso, R. Marth, C. Nooij, M. Presti, M. Scarabelli, C. Splinter, T.A.W. Ploch, E. Beex, L.V.A. ten Bokkel Huinink, W. Forni, M. Melpignano, M. Blake, P. Kerbrat, P. Mendiola, C. Cervantes, A. Goupil, A. Harper, P.G. Madronal, C. Namer, M. Scarfone, G. Stoot, J.E.G.M. Teodorovic, I. Coens, C. Vergote, I. Vermorken, J.B.